Combined antiviral activity of interferon-α and RNA interference directed against hepatitis C without affecting vector delivery and gene silencing
about
siRNAs: potential therapeutic agents against hepatitis C virusConstruction of permanently inducible miRNA-based expression vectors using site-specific recombinasesDisturbance of the microRNA pathway by commonly used lentiviral shRNA libraries limits the application for screening host factors involved in hepatitis C virus infection.Therapeutics Based on microRNA: A New Approach for Liver CancerPossibilities for RNA interference in developing hepatitis C virus therapeutics.Development and optimization of nanosomal formulations for siRNA delivery to the liverConvergent Transcription of Interferon-stimulated Genes by TNF-α and IFN-α Augments Antiviral Activity against HCV and HEV.Antiviral RNAi: translating science towards therapeutic success.Therapeutic potential of RNA interference: a new molecular approach to antiviral treatment for hepatitis C.A competitive cell growth assay for the detection of subtle effects of gene transduction on cell proliferation.Down-regulation of IRES containing 5'UTR of HCV genotype 3a using siRNAs.Inhibition of hepatitis C virus genotype 3a by siRNAs targeting envelope genes.Down regulation of TRIF, TLR3, and MAVS in HCV infected liver correlates with the outcome of infection.RNA interference: a promising approach for the treatment of viral hepatitis.Promiscuous prediction and conservancy analysis of CTL binding epitopes of HCV 3a viral proteome from Punjab Pakistan: an in silico approach.Basal interferon signaling and therapeutic use of interferons in controlling rotavirus infection in human intestinal cells and organoids.Mobilization of hepatic mesenchymal stem cells from human liver grafts
P2860
Q27694682-4B583DAA-6244-44EC-AE4C-121078D191E0Q28253107-22A47400-6383-4E77-B0A4-B106B9EAE5A1Q33837562-F92F609E-4854-4158-A73F-E38F07C4177DQ34152847-DA860CE5-DDD8-42B5-A53E-7D271639BAB5Q35261143-B88BBB94-9400-4A81-BCD2-7BEDECD3A806Q35816825-14FCD7A8-AE1A-4426-810A-C3BB6C4C9C3FQ36009894-AABCC0A5-8D0B-4FD1-B7EF-89CE0DC74212Q37914065-21110371-66E8-45E0-837B-D37E0164AC39Q38050165-24CEF4D9-E630-4F9B-BCD1-679FDADE6A3AQ39437932-16A819DA-D19F-4563-BC28-43AA07BB11EFQ39543313-9AE54986-142C-4AF4-A61E-7A986A572F68Q39619568-096261FD-C54B-40F9-A43C-A7EF9E21A45DQ40211217-B8F2301C-8D15-42EC-B205-FE0D8DFC95F2Q42096848-4D37365A-403E-4927-9A9C-77C39C71D104Q42622697-79E8D0B3-75B1-48E9-9E75-54465B48108BQ55209357-379C5028-8CC1-435B-ACB1-BF1DC6D3843BQ57619010-14061A3A-082F-4B76-B58C-3B29C75AA0F7
P2860
Combined antiviral activity of interferon-α and RNA interference directed against hepatitis C without affecting vector delivery and gene silencing
description
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
article scientifique (publié 2009-07)
@fr
articolo scientifico (pubblicato il 2009-07)
@it
artigo científico (publicado na 2009-07)
@pt
artículu científicu espublizáu en 2009
@ast
im Juli 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: July 2009)
@en
vedecký článok (publikovaný 2009-07)
@sk
videnskabelig artikel (udgivet 2009-07)
@da
name
Combined antiviral activity of ...... or delivery and gene silencing
@ast
Combined antiviral activity of ...... or delivery and gene silencing
@en
Combined antiviral activity of ...... or delivery and gene silencing
@nl
type
label
Combined antiviral activity of ...... or delivery and gene silencing
@ast
Combined antiviral activity of ...... or delivery and gene silencing
@en
Combined antiviral activity of ...... or delivery and gene silencing
@nl
prefLabel
Combined antiviral activity of ...... or delivery and gene silencing
@ast
Combined antiviral activity of ...... or delivery and gene silencing
@en
Combined antiviral activity of ...... or delivery and gene silencing
@nl
P2093
P2860
P1476
Combined antiviral activity of ...... or delivery and gene silencing
@en
P2093
Bob Scholte
Harry L A Janssen
Herold J Metselaar
Hugo W Tilanus
Jaap Kwekkeboom
Scot D Henry
P2860
P2888
P304
P356
10.1007/S00109-009-0470-3
P577
2009-04-30T00:00:00Z
P5875
P6179
1010254426